| |
Author  |
Title |
Year |
Publication |
Volume |
Pages |
Links |
|
|
Vershkov, D.; Benvenisty, N. |
Human pluripotent stem cells in modeling human disorders: the case of fragile X syndrome |
2017 |
Regenerative Medicine |
12 |
53-68 |
|
|
|
Thomas, A.A.; Abrey, L.E.; Terziev, R.; Raizer, J.; Martinez, N.L.; Forsyth, P.; Paleologos, N.; Matasar, M.; Sauter, C.S.; Moskowitz, C.; Nimer, S.D.; DeAngelis, L.M.; Kaley, T.; Grimm, S.; Louis, D.N.; Cairncross, J.G.; Panageas, K.S.; Briggs, S.; Faivre, G.; Mohile, N.A.; Mehta, J.; Jonsson, P.; Chakravarty, D.; Gao, J.; Schultz, N.; Brennan, C.W.; Huse, J.T.; Omuro, A. |
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma |
2017 |
Neuro-Oncology |
19 |
1380-1390 |
|
|
|
Tahara, T.; Hirata, I.; Nakano, N.; Nagasaka, M.; Nakagawa, Y.; Shibata, T.; Ohmiya, N. |
Comprehensive DNA Methylation Profiling of Inflammatory Mucosa in Ulcerative Colitis |
2017 |
Inflammatory Bowel Diseases |
23 |
165-173 |
|
|
|
Sullivan, K.E.; Rojas, K.; Cerione, R.A.; Nakano, I.; Wilson, K.F. |
The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells |
2017 |
Oncotarget |
8 |
22325-22343 |
|
|
|
Spencer, D.A.; Auffinger, B.M.; Murphy, J.P.; Muroski, M.E.; Qiao, J.; Gorind, Y.; Lesniak, M.S. |
Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy |
2017 |
Current Cancer Drug Targets |
17 |
236-254 |
|
